CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 

Pfizer Inc's Quick Ratio

PFE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




PFE Quick Ratio (Jul 04 2021)
II. Quarter
(Apr 04 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 27 2020)
III. Quarter
(Jun 28 2020)
II. Quarter
Y / Y Current Liabilities Change 8.99 % -27.41 % -30.52 % -7.63 % 2.16 %
Y / Y Cash & cash equivalent Change -4.8 % 32.05 % 24.32 % 141.14 % 76.53 %
Quick Ratio MRQ 0.61 0.56 0.47 0.64 0.7
Overall Ranking # # # # #
Seq. Current Liabilities Change 44.98 % -5.09 % -24.11 % 4.37 % -3.44 %
Seq. Cash & cash equivalent Change 58.78 % 11.83 % -44.23 % -3.87 % 120.23 %



Quick Ratio second quarter 2021 Comment
Pfizer Inc's Cash & cash equivalent grew by 58.78 % in II. Quarter sequntially, faster than Current Liabilities, this led to improvement in Pfizer Inc's Quick Ratio to 0.61, Quick Ratio remained below Pfizer Inc average.

Within Major Pharmaceutical Preparations industry 352 other companies have achieved higher Quick Ratio than Pfizer Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are PFE Segments?
See Quick Ratio PFE on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 353
Healthcare Sector # 795
Overall Market # 2950


Quick Ratio Statistics
High Average Low
2.19 0.91 0.25
(June 30. 2009)   (Sep 29 2019)




Financial Statements
Pfizer Inc's Current Liabilities $ 35,664 Millions Visit PFE's Balance sheet
Pfizer Inc's Cash & cash equivalent $ 21,700 Millions Visit PFE's Balance sheet
Source of PFE's Sales Visit PFE's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJul 04 2021, within Major Pharmaceutical Preparations Industry Quick RatioJul 04 2021 MRQ Cash & cash equivalentJul 04 2021 MRQ Current Liabilities
Innovation Pharmaceuticals Inc   1.57 $ 10.272  Millions$ 6.538  Millions
Regeneron Pharmaceuticals Inc   1.57 $ 3,910.800  Millions$ 2,494.000  Millions
Omeros Corporation  1.54 $ 73.658  Millions$ 47.697  Millions
Dar Bioscience Inc   1.52 $ 9.112  Millions$ 6.005  Millions
Alpine Immune Sciences Inc   1.51 $ 91.060  Millions$ 60.246  Millions
Evolus Inc   1.51 $ 131.737  Millions$ 87.286  Millions
Harrow Health Inc   1.50 $ 12.209  Millions$ 8.144  Millions
Akebia Therapeutics Inc   1.49 $ 246.992  Millions$ 165.595  Millions
Cumberland Pharmaceuticals Inc   1.46 $ 25.670  Millions$ 17.579  Millions
Alkermes Plc   1.40 $ 538.345  Millions$ 383.442  Millions
Clovis Oncology inc   1.32 $ 230.204  Millions$ 173.879  Millions
Prestige Consumer Healthcare Inc   1.31 $ 163.624  Millions$ 125.046  Millions
Sonnet Biotherapeutics Holdings Inc   1.30 $ 6.038  Millions$ 4.660  Millions
Radius Health inc   1.23 $ 99.173  Millions$ 80.647  Millions
Endo International Plc  1.19 $ 1,673.730  Millions$ 1,409.212  Millions
Arctos Northstar Acquisition Corp   1.18 $ 0.700  Millions$ 0.592  Millions
One World Pharma Inc   1.17 $ 1.879  Millions$ 1.608  Millions
Nature s Sunshine Products inc   1.15 $ 74.902  Millions$ 64.992  Millions
Shineco Inc   1.10 $ 16.343  Millions$ 14.795  Millions
Dicerna Pharmaceuticals Inc   1.07 $ 221.210  Millions$ 207.650  Millions
Organogenesis Holdings Inc   1.06 $ 89.790  Millions$ 84.545  Millions
Lannett Company Inc  1.03 $ 93.286  Millions$ 90.469  Millions
Bellicum Pharmaceuticals Inc   1.01 $ 20.278  Millions$ 20.140  Millions
Johnson and Johnson  0.96 $ 25,306.000  Millions$ 26,271.000  Millions
Amphastar Pharmaceuticals Inc   0.96 $ 119.377  Millions$ 124.549  Millions
Horizon Therapeutics Public Limited Company  0.96 $ 816.158  Millions$ 852.810  Millions
Lifevantage Corp  0.92 $ 23.174  Millions$ 25.199  Millions
Biohaven Pharmaceutical Holding Company Ltd   0.92 $ 366.107  Millions$ 399.132  Millions
Collegium Pharmaceutical inc   0.89 $ 202.771  Millions$ 226.843  Millions
Catalent Inc   0.81 $ 967.000  Millions$ 1,196.000  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VIRC's Profile

Stock Price

VIRC's Financials

Business Description

Fundamentals

Charts & Quotes

VIRC's News

Suppliers

VIRC's Competitors

Customers & Markets

Economic Indicators

VIRC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071